← Open Payments lookup

BRIAN BEA: Open Payments

NPI 1619915808 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$480 in 29 payments from 10 companies in 2025. Trend: 2023 $595 · 2024 $432 · 2025 $480

Food & beverage: $480
CompanyPaymentsAmount
Amgen Inc.13$187
Lundbeck LLC5$105
GlaxoSmithKline, LLC.3$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$32
Phathom Pharmaceuticals, Inc.1$26
Otsuka America Pharmaceutical, Inc.1$21
Lilly USA, LLC1$16
E.R. Squibb & Sons, L.L.C.1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16
Exact Sciences Corporation1$14

Products named: EVENITY, REXULTI, TRELEGY ELLIPTA, XIFAXAN, OTEZLA, VOQUEZNA, ZEPBOUND, CAMZYOS.

Industry payments across WA — which companies pay providers there.